Just became holder 2 days ago. Question is that in the event of a pharma buyout which could happen,
because here are not many shares available, does that equate to a larger figure per share in a buyout situation?
Might be an obvious conclusion, but was looking for some clarity on that.
Ann: Neuren adds Prader-Willi syndrome to NNZ-2591 pipeline, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.88 |
Change
-0.080(0.62%) |
Mkt cap ! $1.602B | |||
| Open | High | Low | Value | Volume |
| $12.82 | $13.02 | $12.70 | $861.3K | 67.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 17 | $12.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.90 | 125 | 1 |
View Market Depth
| Last trade - 10.45am 17/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |